drugset / Trial / NCT00304681
An Effectiveness and Safety Study of CONCERTA* vs. Immediate Release Methylphenidate (IR MPH) in Attention Deficit Hyperactivity Disorder Children
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the effectiveness and safety of OROS\*methylphenidate/CONCERTA\* vs. immediate release methylphenidate as a treatment for ADHD specifically for those children who have behavioural difficulties in the afternoon/after-school and evening periods.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- 2004-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylphenidate | Small molecule | 18 mg | Oral |
| Subject | Methylphenidate | Small molecule | 27 mg | Oral |
| Subject | Methylphenidate | Small molecule | 36 mg | Oral |
| Subject | Methylphenidate | Small molecule | 54 mg | Oral |